281 related articles for article (PubMed ID: 16332622)
21. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
Pfohl-Leszkowicz A; Manderville RA
Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
[TBL] [Abstract][Full Text] [Related]
22. Ochratoxin A and β2-microglobulin in BEN patients and controls.
Yordanova P; Wilfried K; Tsolova S; Dimitrov P
Toxins (Basel); 2010 Apr; 2(4):780-92. PubMed ID: 22069610
[TBL] [Abstract][Full Text] [Related]
23. Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic?
Abid S; Hassen W; Achour A; Skhiri H; Maaroufi K; Ellouz F; Creppy E; Bacha H
Hum Exp Toxicol; 2003 Feb; 22(2):77-84. PubMed ID: 12693831
[TBL] [Abstract][Full Text] [Related]
24. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers?
Castegnaro M; Chernozemsky IN; Hietanen E; Bartsch H
Arch Geschwulstforsch; 1990; 60(4):295-303. PubMed ID: 2202269
[TBL] [Abstract][Full Text] [Related]
25. Risk estimation for ochratoxin A in European countries.
Frank HK
IARC Sci Publ; 1991; (115):321-5. PubMed ID: 1820348
[TBL] [Abstract][Full Text] [Related]
26. Balkan endemic nephropathy: an update on its aetiology.
Stiborová M; Arlt VM; Schmeiser HH
Arch Toxicol; 2016 Nov; 90(11):2595-2615. PubMed ID: 27538407
[TBL] [Abstract][Full Text] [Related]
27. Human exposure to ochratoxin A in areas of Yugoslavia with endemic nephropathy.
Plestina R; Ceović S; Gatenbeck S; Habazin-Novak V; Hult K; Hökby E; Krogh P; Radić B
J Environ Pathol Toxicol Oncol; 1990; 10(3):145-8. PubMed ID: 2254862
[TBL] [Abstract][Full Text] [Related]
28. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins.
Pfohl-Leszkowicz A; Petkova-Bocharova T; Chernozemsky IN; Castegnaro M
Food Addit Contam; 2002 Mar; 19(3):282-302. PubMed ID: 11834078
[TBL] [Abstract][Full Text] [Related]
29. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria.
Petkova-Bocharova T; Castegnaro M
Food Addit Contam; 1985; 2(4):267-70. PubMed ID: 4065392
[TBL] [Abstract][Full Text] [Related]
30. Relevance of a rat model of papillary necrosis and upper urothelial carcinoma in understanding the role of ochratoxin A in Balkan endemic nephropathy and its associated carcinoma.
Bach PH; Gregg NJ; Delacruz L
Food Chem Toxicol; 1992 Mar; 30(3):205-11. PubMed ID: 1618444
[TBL] [Abstract][Full Text] [Related]
31. Human exposure to ochratoxin A.
Fuchs R; Radić B; Ceović S; Sostarić B; Hult K
IARC Sci Publ; 1991; (115):131-4. PubMed ID: 1820325
[TBL] [Abstract][Full Text] [Related]
32. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A.
Mantle P; Kulinskaya E; Nestler S
Food Addit Contam; 2005; 22 Suppl 1():58-64. PubMed ID: 16332623
[TBL] [Abstract][Full Text] [Related]
33. Concentrations of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: lack of detection of 4-hydroxyochratoxin A.
Castegnaro M; Maru V; Petkova-Bocharova T; Nikolov I; Bartsch H
IARC Sci Publ; 1991; (115):165-9. PubMed ID: 1820331
[TBL] [Abstract][Full Text] [Related]
34. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
[TBL] [Abstract][Full Text] [Related]
35. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
Malir F; Ostry V; Pfohl-Leszkowicz A; Roubal T
Biomarkers; 2012 Nov; 17(7):577-89. PubMed ID: 22642623
[TBL] [Abstract][Full Text] [Related]
36. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia.
Ceović S; Plestina R; Miletić-Medved M; Stavljenić A; Mitar J; Vukelić M
IARC Sci Publ; 1991; (115):5-10. PubMed ID: 1820354
[TBL] [Abstract][Full Text] [Related]
38. Balkan endemic nephropathy: a decreasing incidence of the disease.
Cukuranovic R; Petrovic B; Cukuranovic Z; Stefanovic V
Pathol Biol (Paris); 2000 Jul; 48(6):558-61. PubMed ID: 10965534
[TBL] [Abstract][Full Text] [Related]
39. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.
Pfohl-Leszkowicz A; Castegnaro M
Food Addit Contam; 2005; 22 Suppl 1():75-87. PubMed ID: 16332625
[TBL] [Abstract][Full Text] [Related]
40. Occurrence and significance of ochratoxin A in food.
Castegnaro M; Dirheimer G
Food Addit Contam; 1998 Jan; 15(1):123-4. PubMed ID: 9534879
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
